Systemic Treatment for Brain Metastasis and Leptomeningeal Disease in Breast Cancer Patients

被引：0
|
作者：
Sushant Puri
Amina Chaudhry
Asnakech Bayable
Ashwin Ganesh
Ahmad Daher
Vijayakrishna K. Gadi
Stefania Maraka
机构：
[1] National Institutes of Health,Neurooncology Branch, National Cancer Institute
[2] Johns Hopkins Hospital,Department of Oncology, Sidney Kimmel Cancer Center
[3] University of Illinois at Chicago,Division of Hematology and Oncology, Department of Medicine
[4] University of Illinois at Chicago,Department of Neurology& Rehabilitation
[5] University of Illinois Cancer Center,Translational Oncology Program
来源：
Current Oncology Reports | 2023年 / 25卷
关键词：
Breast cancer; Brain metastases; Leptomeningeal disease; Systemic treatment; HER2+ breast cancer; Triple negative breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1419 / 1430
页数：11
相关论文
共 50 条
  • [41] Chemotherapy and biological treatment options in breast cancer patients with brain metastasis: an update
    Arslan, Cagatay
    Dizdar, Omer
    Altundag, Kadri
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (12) : 1643 - 1658
  • [42] Medical management of brain metastases and leptomeningeal disease in patients with breast carcinoma
    Bowman, Kelsey M.
    Kumthekar, Priya
    FUTURE ONCOLOGY, 2018, 14 (04) : 391 - 407
  • [43] Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis
    Park, Won-Young
    Kim, Han-Jo
    Kim, Kyoungha
    Bae, Sang-Byung
    Lee, Namsu
    Lee, Kyu-Taek
    Won, Jong-Ho
    Park, Hee-Sook
    Lee, Sang-Cheol
    CANCER RESEARCH AND TREATMENT, 2016, 48 (02): : 843 - 847
  • [44] Triple Negative Breast Cancer with Isolated Leptomeningeal Metastasis
    Sampathkumar, N. S.
    Sambasivaiah, K.
    Suresh, Naga M.
    Ramakrishna
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2008, 29 (02) : 30 - 32
  • [45] Updates in the management of brain(leptomeningeal) metastasis of lung cancer
    Ziyi Sun
    Yuan Chen
    Oncology and Translational Medicine, 2018, 4 (04) : 144 - 150
  • [46] Pharmacotherapy for leptomeningeal disease in breast cancer
    Bartsch, Rupert
    Jerzak, Katarzyna J.
    Larrouquere, Louis
    Mueller, Volkmar
    Le Rhun, Emilie
    CANCER TREATMENT REVIEWS, 2024, 122
  • [47] Leptomeningeal metastasis from systemic cancer: Review and update on management
    Wang, Nancy
    Bertalan, Mia S.
    Brastianos, Priscilla K.
    CANCER, 2018, 124 (01) : 21 - 35
  • [48] Management of leptomeningeal metastasis in patients with lung cancer
    Umemura, Shigeki
    LUNG CANCER MANAGEMENT, 2013, 2 (06) : 445 - 447
  • [49] Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)
    Niikura, Naoki
    Yamanaka, Takashi
    Nomura, Hironori
    Shiraishi, Kazuhiro
    Kusama, Hiroki
    Yamamoto, Mitsugu
    Matsuura, Kazuo
    Inoue, Kenichi
    Takahara, Sachiko
    Kita, Shosuke
    Yamaguchi, Miki
    Aruga, Tomoyuki
    Shibata, Nobuhiro
    Shimomura, Akihiko
    Ozaki, Yuri
    Sakai, Shuji
    Kiga, Yoko
    Izutani, Tadahiro
    Shiosakai, Kazuhito
    Tsurutani, Junji
    NPJ BREAST CANCER, 2023, 9 (01)
  • [50] Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients
    Park, Y. H.
    Park, M. J.
    Ji, S. H.
    Yi, S. Y.
    Lim, D. H.
    Nam, D. H.
    Lee, J-I
    Park, W.
    Choi, D. H.
    Huh, S. J.
    Ahn, J. S.
    Kang, W. K.
    Park, K.
    Im, Y-H
    BRITISH JOURNAL OF CANCER, 2009, 100 (06) : 894 - 900
12345